Literature DB >> 32021607

Interstitial 4q Deletion Syndrome Including NR3C2 Causing Pseudohypoaldosteronism.

Amanda Barone Pritchard1,2, Alyssa Ritter1, Hutton M Kearney3, Kosuke Izumi1.   

Abstract

Interstitial and terminal deletions of chromosome 4q have been described for many years and have variable phenotypes depending on the size of the deletion present. Clinical features can include developmental delay, growth difficulty, digital differences, dysmorphic features, and cardiac anomalies. Here, we present an infant with pseudohypoaldosteronism found to have a deletion of 4q31.21q31.23, including NR3C2. Heterozygous mutations in NR3C2 have been reported to cause autosomal dominant pseudohypoaldosteronism type 1 (PHA1A). This represents a rare case of PHA1A due to a contiguous interstitial deletion and highlights the importance of evaluating patients with overlapping deletions for PHA1A.
Copyright © 2019 by S. Karger AG, Basel.

Entities:  

Keywords:  4q- syndrome; Chromosomal microarray; Deletion syndrome; NR3C2; Pseudohypoaldosteronism

Year:  2019        PMID: 32021607      PMCID: PMC6995944          DOI: 10.1159/000505279

Source DB:  PubMed          Journal:  Mol Syndromol        ISSN: 1661-8769


  17 in total

1.  Mineralocorticoid receptor mutations are the principal cause of renal type 1 pseudohypoaldosteronism.

Authors:  Lucie Pujo; Jérôme Fagart; Françoise Gary; Dimitris T Papadimitriou; Aurélie Claës; Xavier Jeunemaître; Maria-Christina Zennaro
Journal:  Hum Mutat       Date:  2007-01       Impact factor: 4.878

2.  Interstitial deletion of the distal long arm of chromosome 4.

Authors:  P Sarda; G Lefort; J P Fryns; C Humeau; D Rieu
Journal:  J Med Genet       Date:  1992-04       Impact factor: 6.318

3.  The 4q-syndrome: delineation of the minimal critical region to within band 4q31.

Authors:  S P Robertson; K O'Day; A Bankier
Journal:  Clin Genet       Date:  1998-01       Impact factor: 4.438

Review 4.  An interstitial 4q31.21q31.22 microdeletion associated with developmental delay: case report and literature review.

Authors:  Angeliki-Maria Vlaikou; Emmanouil Manolakos; Dimitrios Noutsopoulos; Georgios Markopoulos; Thomas Liehr; Annalisa Vetro; Monika Ziegler; Anja Weise; Katharina Kreskowski; Ioannis Papoulidis; Loretta Thomaidis; Maria Syrrou
Journal:  Cytogenet Genome Res       Date:  2014-04-09       Impact factor: 1.636

5.  Elucidating the underlying molecular pathogenesis of NR3C2 mutants causing autosomal dominant pseudohypoaldosteronism type 1.

Authors:  Felix G Riepe; Johannes Finkeldei; Luisa de Sanctis; Silvia Einaudi; Alberto Testa; Beate Karges; Michael Peter; Matthias Viemann; Joachim Grötzinger; Wolfgang G Sippell; Geza Fejes-Toth; Nils Krone
Journal:  J Clin Endocrinol Metab       Date:  2006-09-05       Impact factor: 5.958

6.  The 4q-Syndrome.

Authors:  E M Strehle; O A Ahmed; M Hameed; A Russell
Journal:  Genet Couns       Date:  2001

7.  Autosomal dominant pseudohypoaldosteronism type 1: mechanisms, evidence for neonatal lethality, and phenotypic expression in adults.

Authors:  David S Geller; Junhui Zhang; Maria-Christina Zennaro; Alberto Vallo-Boado; Juan Rodriguez-Soriano; Laszlo Furu; Robert Haws; Daniel Metzger; Barbara Botelho; Lefkothea Karaviti; Andrea M Haqq; Howard Corey; Sandra Janssens; Pierre Corvol; Richard P Lifton
Journal:  J Am Soc Nephrol       Date:  2006-04-12       Impact factor: 10.121

8.  Genotype-phenotype analysis of 4q deletion syndrome: proposal of a critical region.

Authors:  Eugen-Matthias Strehle; Linbo Yu; Jill A Rosenfeld; Sandra Donkervoort; Yulin Zhou; Tian-Jian Chen; Jose E Martinez; Yao-Shan Fan; Deborah Barbouth; Hongbo Zhu; Alicia Vaglio; Rosemarie Smith; Cathy A Stevens; Cynthia J Curry; Roger L Ladda; Zheng Jane Fan; Joyce E Fox; Judith A Martin; Hoda Z Abdel-Hamid; Elizabeth A McCracken; Barbara C McGillivray; Diane Masser-Frye; Taosheng Huang
Journal:  Am J Med Genet A       Date:  2012-07-27       Impact factor: 2.802

9.  Autosomal dominant pseudohypoaldosteronism type 1 in an infant with salt wasting crisis associated with urinary tract infection and obstructive uropathy.

Authors:  Sasigarn A Bowden; Corin Cozzi; Scott E Hickey; Devon Lamb Thrush; Caroline Astbury; Sushma Nuthakki
Journal:  Case Rep Endocrinol       Date:  2013-12-19

10.  Deletion of 4q28.3-31.23 in the background of multiple malformations with pulmonary hypertension.

Authors:  Balazs Duga; Marta Czako; Katalin Komlosi; Kinga Hadzsiev; Katalin Torok; Katalin Sumegi; Peter Kisfali; Gyorgy Kosztolanyi; Bela Melegh
Journal:  Mol Cytogenet       Date:  2014-06-05       Impact factor: 2.009

View more
  2 in total

1.  Analysis of genetic characteristics of 436 children with dysplasia and detailed analysis of rare karyotype.

Authors:  Zong-Yu Miao; Shi-Feng Chen; Hong Wu; Xiao-Yan Liu; Hui-Yuan Shao
Journal:  Open Life Sci       Date:  2022-04-26       Impact factor: 1.311

2.  A Neonate with Autosomal Dominant Pseudohypoaldosteronism Type 1 Due to a Novel Microdeletion of the NR3C2 Gene at 4q31.23.

Authors:  Su Jin Kim; Dasom Park; Woori Jang; Juyoung Lee
Journal:  Children (Basel)       Date:  2021-11-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.